Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CARM Relative to the S&P 500

CARM Relative to the Sector

Seasonal Chart Analysis

Analysis of the Carisma Therapeutics, Inc. (OTCMKT:CARM) seasonal charts above shows that a Buy Date of April 8 and a Sell Date of June 29 has resulted in a geometric average return of 37.94% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 137.94% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.

To download CARM seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CARM